Locally advanced rectal cancer: Added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy

Radiology

Volumn 253, Issue 1, 2009, Pages 116-125

  Kim, Seung Ho ^a   Lee, Jeong Min ^a   Hong, Sung Hyun ^b   Kim, Gi Hyeon ^c   Lee, Jae Young ^a   Han, Joon Koo ^a   Choi, Byung Ihn ^a  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Chung Ang University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BISACODYL; FLUOROURACIL; SCOPOLAMINE BUTYL BROMIDE;

ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RECTUM CANCER; ADJUVANT CHEMOTHERAPY; COMPUTER ASSISTED DIAGNOSIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; RECTUM TUMOR; ROC CURVE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; ROC CURVE; TREATMENT OUTCOME;

EID: 70350520050     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2532090027     Document Type: Article

References (41)

1. Janjan NA, Crane C, Feig BW, et al. Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 2001;24:107-112.
2. Valentini V, Coco C, Picciocchi A, et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? a long term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002;53:664-674.
3. Theodoropoulos G, Wise WE, Padmanabhan A, et al. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival. Dis Colon Rectum 2002;45:895-903.
4. Garcia-Aguilar J, Hernandez de Anda E, Sirivongs P, Lee SH, Madoff RD, Rothenberger DA. A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision. Dis Colon Rectum 2003;46:298-304.
5. Chan AK, Wong A, Jenken D, Heine J, Buie D, Johnson D. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005;61:665-677.
6. Hartley A, Ho K, McConkey C, et al. Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 2005;78:934-938.
7. Stipa F, Chessin DB, Shia J, et al. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieved no downstaging on the basis of preoperative endorectal ultrasonography. Ann Surg Oncol 2006;13:1047-1053.
8. Hughes R, Glynne-Jones R, Grainger J, et al. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? Int J Colorectal Dis 2006;21:11-17.
9. Brown CL, Ternent CA, Thorson AG, et al. Response to preoperative chemoradiation in stage II and III rectal cancer. Dis Colon Rectum 2003;46:1189-1193.
10. Bonnen M, Crane C, Vauthey J, et al. Long-term results using local excision after preoperative chemoradiation among selected T3 cancer patients. Int J Radiat Oncol Biol Phys 2004;60:1098-1105.
11. Habr-Gama A, Perez R, Nadalin W, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 2004;240:711-717.
12. O'Neill BD, Brown G, Heald RJ, Cunningham D, Tait DM. Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. Lancet Oncol 2007;8:625-633.
13. Bujko K, Kepka L, Nowacki MP. Chemoradiotherapy alone for rectal cancer: a word of caution. Lancet Oncol 2007;8:860-862.
14. den Dulk M, van de Velde CJ. Considerations and restrictions for non-operative treatment of rectal cancer in selected patients. Lancet Oncol 2007;8:570-571.
15. Brown G, Radcliffe AG, Newcombe RG, et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003;90:355-364.
16. Beets-Tan RG, Beets GL. Rectal cancer: review with emphasis on MR imaging. Radiology 2004;232:335-346.
17. Maretto I, Pomerri F, Pucciarelli S, et al. The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol 2007;14:455-461.
18. Kuo LJ, Chern MC, Tsou MH, et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis Colon Rectum 2005;48:23-28.
19. Chen CC, Lee RC, Lin JK, Wang LW, Yang SH. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy? Dis Colon Rectum 2005;48:722-728.
20. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188:1622-1635.
21. Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRI - a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 2008;5:220-233.
22. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002;360:307-308.
23. Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 2003;179:641-649.
24. DeVries AF, Kremser C, Hein PA, et al. Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys 2003;56:958-965.
25. Hein PA, Kremser C, Judmaier W, et al. Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol 2003;45:214-222.
26. Abdel Razek AA, Kandeel AY, Soliman N, et al. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and post-treatment changes. AJNR Am J Neuroradiol 2007;28:1146-1152.
27. Razek AA, Megahed AS, Denewer A, Motamed A, Tawfik A, Nada N. Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors. Acta Radiol 2008;49:364-370.
28. Ichikawa T, Erturk SM, Motosugi U, et al. High-B-value diffusion-weighted MRI in colorectal cancer. AJR Am J Roentgenol 2006;187:181-184.
29. Rao SX, Zeng MS, Chen CZ, et al. The value of diffusion-weighted imaging in combination with T2-weighted imaging for rectal cancer detection. Eur J Radiol 2008;65:299-303.
30. Lambregts DMJ, Matos C, Gourtsoyianni S, et al. Value of diffusion weighted MR imaging for predicting tumor response to chemoradiation therapy in patients with advanced rectal cancer [abstr]. In: European Congress of Radiology Annual Meeting Program. Vienna, Austria: European Congress of Radiology, 2009.
31. Ippolito D, Guerra L, Invernizzi F, Sironi S, Fazio F, Messa C. Role of DWI images in the evaluation of tumor regression grade after chemoradiation treatment in patients with rectal cancer: comparison with 18FDG-PET-CT study [abstr]. In: European Congress of Radiology Annual Meeting Program. Vienna, Austria: European Congress of Radiology, 2009.
32. Kim SH, Lee JM, Park HS, Eun HW, Han JK, Choi BI. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging 2009;29:1093-1101.
33. Greene FL, Page DL, Fleming ID, et al. Colon and rectum. In: Fritz A, ed. AJCC cancer staging manual. 6th ed. New York, NY: Springer, 2002; 113-124.
34. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19-23.
35. Kim YH, Kim DY, Kim TH, et al. Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. Int J Radiat Oncol Biol Phys 2005;62:761-768.
36. Kim SH, Lee JM, Lee MW, Kim GH, Han JK, Choi BI. Ultrasound transmission gel as an endorectal contrast agent for tumor visualization of rectal cancer. AJR Am J Roentgenol 2008;191:186-189.
37. Kim SH, Lee JM, Lee MW, Kim GH, Han JK, Choi BI. Diagnostic accuracy of 3.0-Tesla rectal magnetic resonance imaging in preoperative local staging of primary rectal cancer. Invest Radiol 2008;43:587-593.
38. Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer 1994;73:2680-2686.
39. Capirci C, Rampin L, Erba PA, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging 2007;34:1583-1593.
40. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol 2007;188:442-451.
41. Koh DM, Padhani AR. Diffusion-weighted MRI: a new functional clinical technique for tumor imaging. Br J Radiol 2006;79:633-635.